Identification
- Composition (DCI)
- amlodipinevalsartanhydrochlorothiazide
- Manufacturer
- AFRIC-PHAR
- ATC code
- C09DX01
- Presentation
- Boite de 14
- Schedule / Reimb.
- A
- Hospital price
- 64.60 MAD
Indications
Traitement de l’hypertension artérielle essentielle en tant que traitement de substitution chez les patients adultes dont la pression artérielle est suffisamment contrôlée par l’association de l’amlodipine, du valsartan et de l’hydrochlorothiazide (HCTZ), pris soit sous forme de trois composants seuls soit sousforme d’un composant double et d’un composant seul.
Find an open pharmacy
On-call pharmacies near you
About SULIAT HCT 5 MG / 160 MG / 12.5 MG
SULIAT HCT 5 MG / 160 MG / 12.5 MG is marketed in Morocco by AFRIC-PHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of SULIAT HCT 5 MG / 160 MG / 12.5 MG, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about SULIAT HCT 5 MG / 160 MG / 12.5 MG
Answers to common questions from Moroccan patients about this drug.